Here are four things to know about the company’s stock:
• Barclays currently has an overweight rating on the stock.
• K2M has a one-year low of $12.31 and a one-year high of $23.63.
• The stock’s 50-day moving average is $19 and its 200-day moving average is $17.
• The company’s market cap is $859.92 million.
More articles on devices:
Amedica to present CASCADE clinical results
Dr. Jacob Rosenstein performs 1st spinal fusion with Arena-C HA — 5 thing to know
1st reverse shoulder replacement using Zimmer device successfully completed in U.S.
